With an ever-expanding population, patient waiting times in the UK continue to rise and the pressure on RTT, Diagnostic, Surveillance, Cancer and Cancer Screening pathways is at an all-time high. Research suggests that the UK national average for meeting urgent cancer wait targets is only 55%.
The problem? An ageing UK population has put significant additional pressure on our healthcare system, particularly RTT, Diagnostic, Surveillance and Cancer pathways. This, coupled with the increase in skin cancers because of a stronger sun and a relaxed attitude towards skin care, means waiting times and patient backlogs are now higher than ever.
In a country where the population continues to grow and lives longer than ever before, our healthcare system is under increasing pressure to meet demand. Within Ophthalmology, age-related macular degeneration has become more frequent and the number of cataracts has drastically increased. Cancer, RTT, Diagnostic and Surveillance pathways are being impacted by long waiting times and patient backlogs, which results in a lower standard of care for patients.
Due to an ageing population in the UK, the demand for access to healthcare is continually growing. This has resulted in significant pressure on the NHS, particularly for Cancer, RTT, Diagnostic and Surveillance pathways.
The UK population is continually growing larger and living longer. With so many patients requiring quick access to healthcare, the NHS is under significant pressure to meet demand. In the United Kingdom, one person is diagnosed with Breast Cancer every 10 minutes, placing ever-increasing strain on Cancer pathways, as well as RTT, Diagnostic and Surveillance pathways.
We aim to understand and support our NHS in achieving their goals. We work collaboratively with the NHS to provide a high-quality solution to clinical demand, capacity management, capacity restraints and waiting list management for both diagnostic and cancer pathways.